Actively Recruiting
Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section
Led by Tanta University · Updated on 2026-04-14
90
Participants Needed
1
Research Sites
24 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to compare the effect of ondansetron lozenge and intravenous for prevention of shivering in cesarean section (CS).
CONDITIONS
Official Title
Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age from 18 to 40 years.
- American Society of Anesthesiology (ASA) physical status II.
- Parturient women undergoing cesarean section under spinal anesthesia.
You will not qualify if you...
- Parturient women with any contraindication or hypersensitivity to the study drugs.
- Any history of cardiovascular diseases, psychosis, hypertension, fetal distress, or cord prolapse.
- Preoperative shivering.
- Preoperative fever (greater than 386C).
- Body mass index greater than 40 kg/m2.
- Medical history of alcohol or drug abuse.
- Hypo- or hyperthyroidism.
- Parkinson's disease or any extrapyramidal disease.
- Intraoperative blood transfusion.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tanta University
Tanta, El-Gharbia, Egypt, 31527
Actively Recruiting
Research Team
M
Mohammed S Elsharkawy, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here